Health Tech Startup Pitch Deck Template

Health tech pitches have a different burden of proof than typical SaaS or consumer tech pitches. Investors who know the space will ask about regulatory classification, reimbursement pathway, clinical validation, and sales cycle length before they ask about CAC and LTV. Those who don't know the space will ask about unit economics and traction — and then get scared by the complexity when they dig in.

Your pitch deck needs to address both types of investors while demonstrating that you understand healthcare's specific constraints well enough to navigate them.

What Makes Health Tech Pitches Different

Evidence requirements: Healthcare buyers (health systems, payers, employers) increasingly require clinical evidence of efficacy before adopting new technologies. "It makes sense it would work" is not enough in a space where bad decisions harm patients.

Regulatory pathway: If your product is a medical device or software as a medical device (SaMD), you need an FDA strategy. Investors will ask. Not having an answer is disqualifying.

Reimbursement: The question is not just "will hospitals buy this?" but "how does it get paid for?" — which maps to fee-for-service billing, value-based contracts, employer benefits, direct-to-consumer, or grant/government funding.

Sales cycle: Enterprise health system sales cycles are long (12–18 months from first contact to signed contract is common) and involve multiple stakeholders. Unit economics that don't account for this look unrealistic.

Data privacy: HIPAA applies if you handle protected health information. Investors will ask about your BAA strategy and data security architecture.

Slide Structure

Slide 1 — Problem

The clinical or operational problem your technology solves. Use specific, quantified language:

• "Sepsis kills approximately 270,000 patients annually in the US. Early warning systems are underutilized in 80% of community hospitals."
• "38% of patients discharged from the ED for chest pain don't follow up with a cardiologist within 30 days, increasing readmission risk by 2.4x."
• "Mental health appointment wait times average 25 days nationally. 40% of patients who can't get a timely appointment disengage from care entirely."

The problem slide sets the scale of the opportunity. Lead with patient impact, not market size.

Slide 2 — Solution

What you've built and how it addresses the problem. Include:

• A concise product description (one sentence)
• A brief visual: product screenshot, workflow diagram, or mechanism illustration
• The core mechanism of action (how does it actually work?)

Avoid vague technology claims ("AI-powered," "real-time analytics") without explaining what the AI does and what problem the real-time analytics solves. Healthcare investors have seen too many buzzword decks.

Slide 3 — Clinical Validation

This slide separates health tech startups from general tech startups. Show:

• Pilot or study results (even preliminary data from a small cohort is better than none)
• Key metrics: sensitivity/specificity if diagnostic, patient outcomes improvement if therapeutic, cost reduction if operational
• Study design and limitations (be honest — a 50-patient pilot has significant limitations)
• Planned or ongoing validation studies

If you have no clinical data yet, explain your validation roadmap: who you're partnering with, what the study design is, and when you expect data.

Slide 4 — Regulatory Strategy

If your product is or may be classified as SaMD:

• Current FDA classification (Class I, II, or III) or your determination rationale
• 510(k) vs. De Novo vs. PMA pathway
• Current regulatory status (pre-submission, under review, cleared, exempt)
• International regulatory considerations if applicable

If your product is not a medical device, briefly explain why (the line is not always obvious — get a regulatory attorney's opinion before this slide).

Slide 5 — Business Model

How do you get paid?

• SaaS subscription: PMPM (per member per month) for payer/employer models; per-provider or per-site for health systems
• Transactional: Per test, per procedure, per API call
• Value-based: Shared savings, performance-based contracts — attractive to value-based care organizations but requires outcome data
• Direct-to-consumer: DTC health apps that bypass institutional sales
• Licensing: Technology licensing to health systems, device manufacturers, or pharma

Show pricing and contract structure. Sophisticated health tech investors will want to understand average contract value, contract length, and renewal rates.

Slide 6 — Go-to-Market Strategy

Healthcare has a complex stakeholder map. Your GTM slide should explain:

• Who the economic buyer is (CFO, CMO, department head, population health director)
• Who the clinical champion is (the person who advocates for adoption)
• Your entry point and expansion path (land with one department or service line, expand across the health system)
• Which channel you're using: direct sales, channel partners (GPOs, health system groups, payer partnerships), or product-led growth

Include your current sales pipeline structure and why your target customers are your target customers.

Slide 7 — Traction

What evidence do you have that the market wants this?

• Signed customers (de-identified if needed) and logos
• Revenue: ARR, MRR, growth rate
• Pilots in progress and their conversion rate to paid contracts
• Waitlist or letter of intent pipeline
• Key health system or payer partnerships
• Published case studies or peer-reviewed publications

For early-stage health tech, traction often includes pilot results and LOIs before revenue. That's acceptable — frame it clearly.

Slide 8 — Market Size

TAM/SAM/SOM. For health tech:

• TAM: the total US (or global) market for the problem you solve (e.g., sepsis management software — all hospitals with ICUs)
• SAM: the segment you can realistically reach with your current product and GTM
• SOM: what you plan to capture in 3–5 years

Use a bottoms-up calculation where possible: number of target institutions × average contract value. Top-down market size citations from analyst reports are less credible to healthcare investors who know the space.

Slide 9 — Competitive Landscape

Who else is solving this problem, and why do you win?

• Incumbent solutions (what are buyers currently doing instead of your product?)
• Direct competitors (other startups)
• Your specific differentiation: clinical evidence, unit economics, technology moat, exclusive data access, regulatory clearance as a barrier to entry

Avoid the "no real competitors" claim — it signals naivety about the market. Every problem has alternatives.

Slide 10 — Team

In healthcare, domain expertise is a competitive advantage. Show:

• Clinical credentials (MD, PhD, clinical experience) that validate your understanding of the problem
• Regulatory and reimbursement expertise
• Health system sales and go-to-market experience
• Technical depth

Advisory board with recognized names in the relevant clinical domain — genuinely valuable, not just for optics.

Slide 11 — Financial Projections and Ask

Three to five year projections: revenue, gross margin, operating costs, and path to profitability (or the major inflection points). Show assumptions clearly.

The Ask: how much you're raising, what it's for (clinical validation, regulatory clearance, sales team buildout, product development), and the resulting runway.

Slide 12 — Vision

Where does this go? The 10-year version of the company. Health tech investors backing early-stage companies want to understand the larger ambition, not just the near-term product.

---

Notes

Build the deck in slide-deck.io with a clean, professional design. Health tech aesthetics should feel clinical and trustworthy — not loud or consumer-app flashy. Limit to 12–15 slides. Have a technical appendix for due diligence conversations.